THERAXIMAB Trademark

Trademark Overview

On Friday, September 28, 2012, a trademark application was filed for THERAXIMAB with the United States Patent and Trademark Office. The USPTO has given the THERAXIMAB trademark a serial number of 85741201. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 23, 2015. This trademark is owned by TPI. The THERAXIMAB trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer and medical diagnostic reagents
theraximab

General Information

Serial Number85741201
Word MarkTHERAXIMAB
Filing DateFriday, September 28, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 23, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2013

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of cancer and medical diagnostic reagents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 4, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTPI
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60616
Party NameTPI
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60616

Trademark Events

Event DateEvent Description
Monday, November 23, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 23, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 27, 2015EXTENSION 4 GRANTED
Wednesday, April 22, 2015EXTENSION 4 FILED
Wednesday, April 22, 2015TEAS EXTENSION RECEIVED
Wednesday, April 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 27, 2014EXTENSION 3 GRANTED
Wednesday, October 22, 2014EXTENSION 3 FILED
Wednesday, October 22, 2014TEAS EXTENSION RECEIVED
Friday, April 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 24, 2014EXTENSION 2 GRANTED
Tuesday, April 22, 2014EXTENSION 2 FILED
Tuesday, April 22, 2014TEAS EXTENSION RECEIVED
Tuesday, December 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2013EXTENSION 1 GRANTED
Tuesday, October 22, 2013EXTENSION 1 FILED
Saturday, December 7, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 22, 2013TEAS EXTENSION RECEIVED
Tuesday, April 23, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 15, 2013ASSIGNED TO EXAMINER
Thursday, October 4, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

theraximab diagnostic reagents medical cancer preparations treatment pharmaceutical